CERE — Cerevel Therapeutics Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapMomentum Trap

Annual balance sheet for Cerevel Therapeutics Holdings, fiscal year end - December 31st, millions except per share.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:		10-K	10-K	10-K	10-K
Standards:	—	USG	USG	USG	USG
Status:	fx Preliminary	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	—	384	566	892	991
Net Total Receivables	—	—	—	2.05	5.29
Prepaid Expenses
Total Other Current Assets
Total Current Assets	—	391	578	906	1,007
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	48.6	51.7	49.3	45.8
Long Term Investments
Other Long Term Assets
Total Assets	—	445	689	1,018	1,243
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	—	29.5	42.5	72.6	92.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	—	60.8	110	497	570
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	—	385	579	521	674
Total Liabilities & Shareholders' Equity	—	445	689	1,018	1,243
Total Common Shares Outstanding